Emerging Technology Partners

Emerging Technology Partners (ETP) is a specialized venture capital firm based in San Francisco, California, dedicated to investing in early-stage life science companies. The firm's core focus spans a wide array of innovative sectors within the life sciences, including therapeutics, diagnostics, medical devices, and digital health solutions. ETP distinguishes itself by targeting companies that possess promising technologies and are led by strong, experienced management teams, aiming to foster the development of groundbreaking advancements that can significantly impact human health.

ETP's investment philosophy extends beyond mere capital provision; the firm actively engages with its portfolio companies. They leverage their extensive network, deep industry expertise, and operational experience to provide strategic guidance, facilitate partnerships, and assist in navigating the complex landscape of the life science industry. This hands-on approach is designed to accelerate the growth and success of their investments, helping early-stage ventures transition from scientific discovery to commercial viability.

The firm typically provides initial capital ranging from $1 million to $5 million, reflecting its commitment to supporting nascent companies in their critical early phases. Beyond the initial investment, ETP strategically reserves capital for follow-on rounds, demonstrating a long-term commitment to its portfolio companies as they achieve key milestones and require further funding for expansion or clinical development. This structured approach ensures that promising ventures have sustained financial backing throughout their developmental journey.